计算机辅助发现自然化合物,以ADAR2 dsRBD2-RNA接口为目标,并对全长ADAR2蛋白结构进行计算建模
Carolyn N Ashley1, Emmanuel Broni1, Michelle Pena-Martinez1
1Department of Medicine, Loyola University Medical Center, Loyola University Chicago, Maywood, IL 60153, USA.
International journal of molecular sciences
|May 14, 2025
概括
研究人员确定了天然化合物,可以通过抑制ADAR2RNA结合来治疗间皮瘤. 这些化合物显示出作为新型中瘤治疗药物的潜力,为这种攻击性癌症提供了希望.
科学领域:
- 计算化学和药物发现
- 瘤学和癌症治疗学
- 分子生物学和RNA结合蛋白.
背景情况:
- 间皮瘤是一种具有不良预后的侵袭性癌症,通常与接触石棉有关.
- 抑制作用于dsRNA 2 (ADAR2) 结合RNA的腺氨酸脱氨酶显示出对间皮瘤治疗的前景.
- 目前对于中瘤的有效治疗方法有限.
研究的目的:
- 为了识别来自传统中医 (TCM) 的天然化合物,可以与ADAR2的RNA结合域 (dsRBD2) 结合并抑制.
- 评估这些化合物的药物相似性,安全性和结合亲和力.
- 为进一步研究开发高质量的ADAR2模型.
主要方法:
- 对TCM化合物的分子对接到ADAR2 dsRBD2.
- 分子力学Poisson-Boltzmann表面积 (MM/PBSA) 计算的结合亲和力.
- 分子动力学 (MD) 模拟来分析蛋白质-配体-RNA相互作用.
- 开发完整的ADAR2模型.
主要成果:
- 八种化合物对ADAR2 dsRBD2.2具有很高的结合亲和力.
- 四种化合物 (ZINC000085597263,ZINC000085633079,ZINC000014649947,ZINC000034512861) 在RNA基质的存在下显示出负的结合亲缘关系.
- 关键残留物 (Val164,Met165,Lys209,Lys212) 被确定为关键的联体结合,表明抑制ADAR2RNA结合.
- 预测的生物活动和与已知的抗癌剂的结构相似性表明,它对间皮瘤有治疗潜力.
结论:
- 已识别的天然化合物具有抑制ADAR2RNA结合的潜力,为间皮瘤提供了一种新的治疗策略.
- 这些化合物在结构上与现有的抗癌药物有关,因此需要进一步研究和优化用于间皮瘤治疗.
- 开发的ADAR2模型为未来的蛋白质工程和治疗开发提供了宝贵的见解.
关键词:
阿达尔 (ADAR) 是一个叫做ADAR的词.货币货币/PBSA计算方法编辑RNA的RNA编辑计算机辅助的药物发现.在全长ADAR2中.同源性建模的同源性建模半质瘤 (Mesothelioma) 是一种中质瘤.分子动力学模拟,分子动力学模拟自然化合物 自然化合物更多相关视频
10:34Probing RNA Structure with Dimethyl Sulfate Mutational Profiling with Sequencing In Vitro and in Cells
Published on: December 9, 2022
3.9K
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
83
相关概念视频
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
